DLSRAV COVID-19 TESTING SOLUTIONS
The test surveys an individual’s immune responsiveness to Sars-Cov-2 (COVID-19) virus, namely the nucleocapsid and spike proteins. The spike is the main protein used in COVID-19 vaccines. The SCOV™ ANTIBODIES profiles can simultaneously quantify the specificity and antibody response to this protein and may be a useful tool in making immunity assessments to COVID-19. The assay is 100-1000 fold more sensitivity than similar assays presently on the market.
*SCOV™ is a Trademark of DLS Research and Ventures
GA Clinical License ID: 122‐003; CLIA ID: 11D2114053
Copyright© 2021 DLS Research & Ventures; All rights reserved.